Aytu BioScience Inc (AYTU) stock news · rev $66.4M
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
This AYTU news page leads with what Aytu BioScience Inc filed — not a scraped headline mill.
No cached 8-K sentence for AYTU yet. We will not pad this page with generic market recap.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. Revenue was down 18.0% from 2024-06-30 to 2025-06-30. AYTU currently screens at market cap $24.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AYTU stock page; for the tape open the quote page.
AYTU stock news FAQ
What are AYTU's latest revenue and net income?
Latest cached Aytu BioScience Inc (AYTU) revenue for Jun 30, 2025 was $66.4M. Net income was -$13.6M. Statements: https://lician.com/financials/aytu
How did AYTU revenue change from the prior cached period?
Cached Aytu BioScience Inc (AYTU) revenue was down 18.0% from $81.0M (Jun 30, 2024) to $66.4M (Jun 30, 2025). Statements: https://lician.com/financials/aytu
What is AYTU's market cap?
Aytu BioScience Inc (AYTU) market cap is $24.1M on the latest cached fundamentals snapshot.
What kind of company is AYTU?
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Where is AYTU stock news listed?
Cached stock news for Aytu BioScience Inc (AYTU) is listed at https://lician.com/news/aytu. Filings: https://lician.com/sec/aytu
Not investment advice.